Skip to main content
. 2021 Aug 11;22(1):90. doi: 10.1186/s10194-021-01305-8

Fig. 2.

Fig. 2

Economic analysis: Incremental cost-effectiveness ratio (euros spent for each HLY gained) at one year and 5 years, from health-provider perspective (migraine). Note: For tension-type headache and medication-overuse headache, the intervention is not only more cost-effective than current care but also cost saving over 1 and 5 years (see Tables 1, 2 and 3)